Physiological role of NO produced by constitutive NO synthase in pancreatic islet of Langerhans
Physiological role of NO produced by constitutive NO synthase in pancreatic islet of Langerhans
批准号:
13670094
负责人:
ISHIKAWA Tomohisa
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
METHODS: Pancreatic islets of Langerhans and β cells were isolated from male Wistar rats (9-12 weeks old) by collagenase digestion technique. (1) Double immunostaining with antiserum to NOS1 or NOS3 and that to glucagon, insulin, somatostatin, or pancreatic polypeptide was performed in the isolated islets, and the fluorescent images were analyzed in a confocal laser scanning microscope. (2) The production of NO was measured with the fluorescent NO indicator DAF-2 DA in a confocal laser scanning microscope. (3) [Ca^<2+>]i was measured in fura-PE3-loaded β cells by Argus-50/CA system. (4) The secretion of insulin from isolated islets was measured by the batch incubation method and EIA. (5) ATP-sensitive K^+ currents were measured by the patch clamp method.RESULTS AND DISCUSSION: (1) Double immunostaining showed that both NOS1- and NOS3-immunoreactivity are present in rat β celles. (2) Glucose produced NO in the β cells in a concentration-dependent manner. (3) In the presence of L-NNA, the NO donor NOC7 at 0.5 and 1.0 μM increased the amplitude of [Ca^<2+>]i oscillations induced by 11.1 mM glucose, and at 10 μM terminated them. A soluble guanylyl cyclase inhibitor suppressed the stimulatory action of NOC7 at low concentrations, whereas it did not affect the inhibitory one at high concentrations, suggesting that the former is mediated by cGMP but the latter is not. (4) Insulin secretion induced by 11.1 mM glucose was facilitated by 0.5 μM NOC7, whereas it was suppressed by 10 μM NOC7.CONCLUSION: NO is an endogenous regulator of insulin secretion, which facilitates and inhibits glucose-induced insulin secretion at low and high concentrations, respectively
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nakayama et al.: "Interactive role of tyrosine kinase, protein kinase C, and Rho/Rho kinase systems in the mechanotransduction of vascular smooth muscles"Biorheology. 40. 307-314 (2003)
Nakayama 等人:“酪氨酸激酶、蛋白激酶 C 和 Rho/Rho 激酶系统在血管平滑肌机械转导中的相互作用”生物流变学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugino, F. et al.: "Inhibition by nitric oxide of Ca^<2+> responses in rat pancreatic α-cells"Life Sci. 71. 85-93 (2002)
Sugino,F.等人:“一氧化氮对大鼠胰腺α细胞中Ca 2+ 反应的抑制”Life Sci.71.85-93(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa, T. et al.: "Non-contribution of renin-angiotensin system to pressor response to N^G-nitro-L-arginine in dogs"Fundam Clin Pharmacol. 16. 15-21 (2002)
Ishikawa,T.等人:“肾素-血管紧张素系统对狗中N^G-硝基-L-精氨酸的升压反应没有贡献”Fundam Clin Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa et al.: "Non-contribution of renin-angiotensin system to pressor response to N^G-nitro-L-arginine in dogs"Fundamental and Clinical Pharmacology. 16. 15-21 (2002)
Ishikawa 等人:“肾素-血管紧张素系统对狗 N^G-硝基-L-精氨酸的升压反应无贡献”基础和临床药理学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishikawa T., Nejishima H., Imamura T., Nakayama K.: "Non-contribution of renin-angiotensin system to pressor response to N^G-nitro-L-arginine in dogs"Fundam Clin Pharmacol. 16. 15-21 (2002)
Ishikawa T.、Nejishima H.、Imamura T.、Nakayama K.:“肾素-血管紧张素系统对狗 N^G-硝基-L-精氨酸的升压反应无贡献”Fundam Clin Pharmacol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Basic study for developing NASH therapeutic drugs by using a small molecule derived from the cellular slime mold serving as a lead compound
-
批准号:20H04110
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2020
-
负责人:ISHIKAWA Tomohisa
-
依托单位:
Role of crosstalk between peripheral circadian clock and NO-cGMP system of pancreatic beta-cells in the pathogenesis of diabetes
-
批准号:23590192
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:ISHIKAWA Tomohisa
-
依托单位:
Intermolecular network involved in calcium-dependent apoptosis of pancreatic beta-cells and possible targets for diabetes treatment
-
批准号:20590085
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2008
-
负责人:ISHIKAWA Tomohisa
-
依托单位:
Analysis of intracellular mechanisms contributing to insulin secretion from pancreatic β-cells
-
批准号:11670097
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1999
-
负责人:ISHIKAWA Tomohisa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: